NARA — Pangenomic Health Share News
0.000.00%
- CA$3.27m
- CA$3.24m
REG-PanGenomic Health Inc: PanGenomic Health Announces Changes to Board of Directors
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Announces Changes to Board of Directors
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Subsidiary Introduces Point-of-Care Vitamin D Test for the Dental Implant Industry
AnnouncementREG-PanGenomic Health Inc: Total Voting Rights
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Announces Q3 Financial Results
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Intends to Close Shares for Debt Settlement
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Announces Financial Results for Half Year Ended 30 June 2023
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement
AnnouncementREG-PanGenomic Health Inc: Board Changes
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Provides Update for NARA Product and Conversational AI
AnnouncementREG-PanGenomic Health Inc: PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform
AnnouncementREG-PanGenomic Health Inc: Annual Financial Results
AnnouncementREG-PanGenomic Health Inc: AGM Results
AnnouncementREG-PanGenomic Health Inc: Subsidiary Update and Repricing of Outstanding Warrants
AnnouncementREG-PanGenomic Health Inc: Admission to Trading on AQSE and First Day of Dealings
Announcement